Nanjing Chemical Reagent Co., Ltd——Sodium dihydrogen phosphate dodecahydrate (for injection)Registration has been completed and officially announced in CDE, with registration number F20250000731. Packaging, 500g/bottle, 25kg/bag (note: packaging specifications can be added according to customer needs without changing the inner packaging material), this indicates that the product has complete registration qualifications and can be directly used for the declaration and production of high-risk preparations such as injections, providing pharmaceutical companies with controllable sources and reliable quality of excipients.


Sodium dihydrogen phosphate dodecahydrate (for injection)(CAS: 10039-32-4) is one of the commonly used buffer salts in injections, widely used for pH adjustment and buffer system construction. Paired with sodium dihydrogen phosphate, it forms a stable phosphate buffer solution (PBS) to maintain protein mRNA、 The structure and activity of biological macromolecules such as vaccines, intravenous nutrient solutions and electrolyte supplements, providing phosphorus elements, participating in energy metabolism and bone health, ophthalmic injections and dialysate, ensuring osmotic pressure and physiological compatibility, freeze-drying protective agent components, improving the solubility and stability of freeze-dried products, etc.


Nanjing Chemical ReagentsSodium dihydrogen phosphate dodecahydrate (for injection)Medicinal excipients achieve full process traceability for each batch of products, from raw material entry to finished product release, with full process control.Nanjing reagentTaking this as an opportunity, we will continue to increase research and development investment, continuously improve product quality and technological level, expand more high-quality varieties of pharmaceutical excipients, and meet the growing demand of the pharmaceutical industry.